Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:43 AM
Ignite Modification Date:
2025-12-25 @ 3:43 AM
NCT ID:
NCT00216502
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of probable Alzheimer's disease according to accepted medical standards
* Patients with mild to moderate impairment of thinking, reasoning, and judgment as defined by a score from 11-24 on the Mini Mental Status Exam (MMSE, a standard assessment tool for Alzheimer's disease) Female patients must be post-menopausal
* Patients and their caregivers must have signed informed consent forms Exclusion Criteria:
* Patients with a diagnosis of Parkinson's Disease, Pick's Disease, Huntington's Chorea, Creutzfeld-Jacob disease, Down's syndrome, brain cancer, mental retardation, epilepsy, psychiatric disease, liver, kidney or heart failure, significant heart, lung, digestive, hormone or mental disease or Vitamin B deficiency
* Patients with previous severe head injury or blood clot in the brain
* Patients who are hospitalized, living in nursing homes or residential care facilities
* Patients with brain infections such as abscess, meningitis, encephalitis
* Patients with a history of drug or alcohol abuse
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
50 Years
Study:
NCT00216502
Study Brief:
Protocol Section:
NCT00216502